Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$1.22 - $1.65 $24,517 - $33,158
-20,096 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.18 - $2.62 $50,207 - $111,478
-42,549 Reduced 67.92%
20,096 $31,000
Q4 2020

Feb 12, 2021

BUY
$1.05 - $2.24 $54,770 - $116,842
52,162 Added 497.59%
62,645 $66,000
Q3 2020

Nov 13, 2020

BUY
$1.7 - $6.41 $17,821 - $67,196
10,483 New
10,483 $21,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Qcm Cayman, Ltd. Portfolio

Follow Qcm Cayman, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Qcm Cayman, Ltd. with notifications on news.